We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
International collaboration establishes new quality standards to improve reliability of gut health studies – improving accuracy to provide better diagnosis and treatment.
As part of #MedSafetyWeek, the MHRA’s Chief Safety Officer reflects in The Pharmacist on the vital role pharmacists play in keeping medicines and medical devices safe.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Siiltibcy
Professor Jacob George has been appointed as the first Chief Medical and Scientific Officer for the Medicines and Healthcare products Regulatory Agency (MHRA).
Professor Henrietta Hughes reflects on how MHRA strategy must prioritise patient safety via listening to lived experiences, fostering collaboration & innovation.
The tenth annual #MedSafetyWeek brings together more than 130 medicines regulators and health organisations across 117 countries to encourage people to report suspected side effects from medicines and device incidents.
New paper sets out UK regulator's intentions to overhaul rulebook for rare disease therapies in UK
As with any medicine, the MHRA will keep the safety and effectiveness of concizumab under close review.
MHRA strikes massive blow to organised criminal gang in world’s biggest illegal weight loss jabs raid.
The government has announced it is slashing the red tape that holds back groundbreaking innovations from coming to market.
The MHRA leads three new government-backed projects using AI-driven approaches to make medicines safer and bring treatments to patients more quickly.
Seven emerging AI healthcare technologies have been selected for the second phase of the MHRA’s AI Airlock programme.
How regulation can spark life-saving innovation.
Developers work with the NHS, the medicines regulator and the UK health technology assessment bodies from the early stages of clinical development, as part of the Innovative Licensing and Access Pathway.
The MHRA produces over 95 per cent of the World Health Organization’s (WHO) biological standards.
The MHRA’s Interim Executive Director of Science and Research writes in The British Medical Journal on the approval of the UK’s first new UTI antibiotic in nearly 30 years, and the wider challenge of tackling antibiotic resi…
Aligned pathway will streamline decisions on licensing and value for medicines, helping patients to benefit from them sooner.
Enhanced collaboration with the US on med tech regulation, with accelerated innovation, strengthened patient safety, and reduced transatlantic barriers to market access.
Patients receive earlier access to life-saving treatments as UK trial approval times cut in half from 91 to just 41 days.
The MHRA is inviting the next generation of doctors to explore how genetics could improve prescribing and patient safety in the UK.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).